Figure 5. Western blot analysis of TTR. Western blotting confirmed that transthyretin (TTR) was statistically significantly increased in branch retinal vein occlusion (BRVO) treated with bevacizumab (p=0.045). A: Retinal content of TTR. B: Densitometric change of relative TTR content between BRVO + NaCl and BRVO with bevacizumab intervention normalized to relative β-actin expression. *p<0.05.